Agilent Technologies Comprehensive Income 2010-2025 | A
Agilent Technologies comprehensive income from 2010 to 2025. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- Agilent Technologies comprehensive income for the quarter ending January 31, 2025 was $-0.381B, a 20.57% increase year-over-year.
- Agilent Technologies comprehensive income for 2024 was $-0.305B, a 6.73% decline from 2023.
- Agilent Technologies comprehensive income for 2023 was $-0.327B, a 5.76% decline from 2022.
- Agilent Technologies comprehensive income for 2022 was $-0.347B, a 23.05% increase from 2021.
| Agilent Technologies Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024 | $-305 |
| 2023 | $-327 |
| 2022 | $-347 |
| 2021 | $-282 |
| 2020 | $-522 |
| 2019 | $-514 |
| 2018 | $-408 |
| 2017 | $-346 |
| 2016 | $-503 |
| 2015 | $-391 |
| 2014 | $-334 |
| 2013 | $91 |
| 2012 | $-111 |
| 2011 | $116 |
| 2010 | $-88 |
| 2009 | $-185 |
| Agilent Technologies Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2025-01-31 | $-381 |
| 2024-10-31 | $-305 |
| 2024-07-31 | $-331 |
| 2024-04-30 | $-337 |
| 2024-01-31 | $-316 |
| 2023-10-31 | $-327 |
| 2023-07-31 | $-271 |
| 2023-04-30 | $-282 |
| 2023-01-31 | $-280 |
| 2022-10-31 | $-347 |
| 2022-07-31 | $-362 |
| 2022-04-30 | $-333 |
| 2022-01-31 | $-298 |
| 2021-10-31 | $-282 |
| 2021-07-31 | $-454 |
| 2021-04-30 | $-452 |
| 2021-01-31 | $-469 |
| 2020-10-31 | $-522 |
| 2020-07-31 | $-476 |
| 2020-04-30 | $-538 |
| 2020-01-31 | $-521 |
| 2019-10-31 | $-514 |
| 2019-07-31 | $-404 |
| 2019-04-30 | $-398 |
| 2019-01-31 | $-381 |
| 2018-10-31 | $-408 |
| 2018-07-31 | $-335 |
| 2018-04-30 | $-310 |
| 2018-01-31 | $-269 |
| 2017-10-31 | $-346 |
| 2017-07-31 | $-417 |
| 2017-04-30 | $-477 |
| 2017-01-31 | $-489 |
| 2016-10-31 | $-503 |
| 2016-07-31 | $-345 |
| 2016-04-30 | $-299 |
| 2016-01-31 | $-438 |
| 2015-10-31 | $-391 |
| 2015-07-31 | $-332 |
| 2015-04-30 | $-270 |
| 2015-01-31 | $-261 |
| 2014-10-31 | $-334 |
| 2014-07-31 | $53 |
| 2014-04-30 | $132 |
| 2014-01-31 | $36 |
| 2013-10-31 | $91 |
| 2013-07-31 | $-173 |
| 2013-04-30 | $-145 |
| 2013-01-31 | $-41 |
| 2012-10-31 | $-111 |
| 2012-07-31 | $-35 |
| 2012-04-30 | $68 |
| 2012-01-31 | $87 |
| 2011-10-31 | $116 |
| 2011-07-31 | $271 |
| 2011-04-30 | $278 |
| 2011-01-31 | $-63 |
| 2010-10-31 | $-88 |
| 2010-07-31 | $-225 |
| 2010-04-30 | $-239 |
| 2010-01-31 | $-201 |
| 2009-10-31 | $-185 |
| 2009-07-31 | $-141 |
| 2009-04-30 | $-188 |
| 2009-01-31 | $-154 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $30.654B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.051B | 28.02 |
| Boston Scientific (BSX) | United States | $155.046B | 38.81 |
| Stryker (SYK) | United States | $146.591B | 30.65 |
| EssilorLuxottica (ESLOY) | France | $128.427B | 0.00 |
| Medtronic (MDT) | Ireland | $106.656B | 15.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.530B | 27.59 |
| ResMed (RMD) | United States | $35.880B | 26.95 |
| GE HealthCare Technologies (GEHC) | United States | $31.512B | 14.96 |
| Terumo (TRUMY) | Japan | $28.279B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.455B | 16.14 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.623B | 11.96 |
| Insulet (PODD) | United States | $18.597B | 79.37 |
| Baxter (BAX) | United States | $15.765B | 11.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.408B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.910B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.514B | 22.02 |
| Lantheus Holdings (LNTH) | United States | $5.512B | 14.05 |
| Prestige Consumer Healthcare (PBH) | United States | $4.033B | 19.25 |
| Perrigo (PRGO) | Ireland | $3.604B | 9.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.310B | 28.20 |
| Haemonetics (HAE) | United States | $3.228B | 15.19 |
| Envista Holdings (NVST) | United States | $2.854B | 23.72 |
| GN Store Nord (GNNDY) | Denmark | $2.010B | 16.65 |
| LeMaitre Vascular (LMAT) | United States | $1.844B | 41.21 |
| QuidelOrtho (QDEL) | United States | $1.744B | 12.02 |
| AtriCure (ATRC) | United States | $1.500B | 0.00 |
| Neogen (NEOG) | United States | $1.287B | 16.47 |
| Green Thumb Industries (GTBIF) | United States | $1.274B | 28.67 |
| Kestra Medical Technologies (KMTS) | United States | $1.121B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.111B | 11.28 |
| BioLife Solutions (BLFS) | United States | $1.014B | 0.00 |
| InMode (INMD) | Israel | $0.989B | 9.06 |
| Phibro Animal Health (PAHC) | United States | $0.785B | 10.05 |
| Evolus (EOLS) | United States | $0.758B | 0.00 |
| Owens & Minor (OMI) | United States | $0.599B | 5.11 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.551B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.435B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.411B | 0.00 |
| Surmodics (SRDX) | United States | $0.388B | 0.00 |
| Omeros (OMER) | United States | $0.370B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 14.59 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.315B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.287B | 24.23 |
| Verano Holdings (VRNOF) | United States | $0.287B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.270B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.258B | 45.90 |
| Cerus (CERS) | United States | $0.249B | 0.00 |
| ZimVie (ZIMV) | United States | $0.248B | 14.83 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.183B | 5.14 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.27 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| Organigram Global (OGI) | Canada | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.39 |
| Jin Medical (ZJYL) | China | $0.126B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.086B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.70 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| United Health Products (UEEC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 11.24 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |